Reflection Biotechnologies (ReflectionBio®) is a patient-driven biotech company. Founded by a rare disease patient, we apply the “By Patients, For Patients” approach for patients to combine efforts in driving #RareDisease and #OrphanDrug R&D. We focus on developing gene therapy and other novel treatments for rare diseases which currently have no or few treatment options available.
| Website | http://www.reflectionbio.com |
| Employees | 1 (1 on RocketReach) |
| Founded | 2015 |
| Phone | +852 3689 8551 |
| Industry | Biotechnology Research, Biotechnology, Gene Therapy, Science and Engineering, Rare Diseases, Orphan Drug Development |
| Keywords | Rare Diseases, Orphan Drugs, Biotechnology, Pharmaceutical Research, Drug Development, Patient Advocacy, Clinical Trials, Biotech Research, Medical Research, Rare Disease Research, Genetic Disorders, Drug Discovery, Personalized Medicine, Therapeutic Development, Healthcare Innovation, Biopharmaceutical, Life Sciences, New Drug Entities, Preclinical Development |
Looking for a particular Reflection Biotechnologies employee's phone or email?
Reflection Biotechnologies Questions
Richard Yang is the Founder and CEO of Reflection Biotechnologies.
1 people are employed at Reflection Biotechnologies.
Top Reflection Biotechnologies Employees
G2Crowd Trusted
300K+
Plugin Users
